Should You Buy NuScale Power While It's Below $50?

NuScale Power has surged more than 20% over the past 30 days but remains down roughly 77% from its all-time high, with a market cap around $4.3 billion versus a stated $10 trillion long-term nuclear opportunity. The article is constructive on the secular SMR thesis, but stresses two risks: commercialization likely not until 2030-2035 and continued extreme volatility for SMR stocks. NuScale’s first system is not expected online until around 2032.

Analysis

The market is pricing SMR names like optionality on a long-dated infrastructure cycle, but the more important near-term setup is not demand — it is financing. Until first-of-a-kind projects demonstrate predictable schedule, cost, and regulatory execution, these equities will trade less like utilities and more like biotech: valuation driven by narrative durability, not cash flow. That creates a structural advantage for the better-capitalized or better-funded player, while weaker balance sheets become forced sellers on any delay or dilution headline.

The second-order winner may actually be the industrial and supply-chain ecosystem, not the reactor developers themselves. Long-lead equipment, specialty fabrication, grid interconnect, and nuclear services names can monetize the buildout earlier because they get paid on engineering and procurement milestones rather than waiting for a commercial fleet to scale. If SMR deployment slips into the 2030s, the addressable equity upside migrates from pure plays to picks-and-shovels exposures with lower binary risk.

Consensus is underestimating how violently these stocks can mean-revert off any change in policy or capital markets conditions. A lower discount rate, AI-driven power procurement, or a credible first deployment can re-rate the group quickly, but a single construction miss, licensing setback, or equity raise can compress multiples by 30-50% in days. The asymmetry is still there, but it is much cleaner via structures that cap downside than via outright longs.

Net-net, the thesis is not wrong, just early. The correct framing is that SMR is a long-duration infrastructure call with embedded volatility and execution risk, not a straight-line growth story. For now, the better trade is to own the enabling ecosystem and express directional views with options rather than cash equity.

Key Decisions for Investors

• Avoid chasing SMR/OKLO after the recent volatility; if initiating, use 6-12 month call spreads instead of stock to cap dilution and execution risk while preserving upside.
• Pair trade: long a diversified nuclear supply-chain basket vs. short SMR/OKLO for 3-6 months to monetize the likely gap between infrastructure spend and delayed reactor revenue recognition.
• Add BAC on pullbacks as a relative beneficiary of rising nuclear capex and project-finance activity; monitor for underwriting commentary that can move the theme before physical deployment does.
• If wanting pure beta to the power-demand narrative, prefer a basket of grid/industrial beneficiaries over SMR developers until there is evidence of commercial schedule fidelity; the risk/reward is superior over the next 12-24 months.
• For existing SMR longs, hedge with short-dated puts into construction/regulatory milestones; these names are highly sensitive to any slip in timeline and can reprice 20-40% quickly on bad execution.